Rybelsus tabletter (semaglutide) er et reseptbelagt legemiddel som brukes hos voksne med type 2 diabetes mellitus for å redusere blodsukkernivået. Rybelsus kan foreskrives når andre diabetesmedisiner har blitt prøvd uten suksess og bør brukes sammen med kosthold og trening. Rybelsus tabletter arbeider for å senke blodsukkernivået (glukose) ved å øke hvor mye insulin som frigjøres og redusere glucagon sekresjon. Denne medisinen kan også bremse gastrisk tømming etter å ha spist.
3mg
Sending
Besparelse
Per tablett
Pris
Ordre
90 tabletter
kr 4836.48
kr 161.35
kr 14521.82
Gratis AirMail sending
60 tabletter
kr 2579.06
kr 172.11
kr 10326.47
Gratis AirMail sending
30 tabletter
kr 967.08
kr 182.86
kr 5485.69
Gratis AirMail sending
20 tabletter
kr 429.75
kr 193.60
kr 3872.09
Gratis AirMail sending
10 tabletter
kr 215.09
kr 2150.92
Gratis AirMail sending
7mg
Sending
Besparelse
Per tablett
Pris
Ordre
90 tabletter
kr 1932.01
kr 193.63
kr 17426.29
Gratis AirMail sending
60 tabletter
kr 965.47
kr 199.00
kr 11940.07
Gratis AirMail sending
30 tabletter
kr 321.64
kr 204.37
kr 6131.12
Gratis AirMail sending
20 tabletter
kr 107.04
kr 209.74
kr 4194.81
Gratis AirMail sending
10 tabletter
kr 215.09
kr 2150.92
Gratis AirMail sending
14mg
Sending
Besparelse
Per tablett
Pris
Ordre
90 tabletter
kr 2416.09
kr 231.28
kr 20814.84
Gratis AirMail sending
60 tabletter
kr 1288.19
kr 236.65
kr 14199.10
Gratis AirMail sending
30 tabletter
kr 483.00
kr 242.02
kr 7260.64
Gratis AirMail sending
20 tabletter
kr 214.61
kr 247.39
kr 4947.82
Gratis AirMail sending
10 tabletter
kr 258.12
kr 2581.21
Gratis AirMail sending
Rybelsus® tablets
What is Rybelsus?
Rybelsus tablets (semaglutide) is a prescription medicine used in adults with type 2 diabetes mellitus to decrease blood sugar levels. Rybelsus can be prescribed when other diabetes medicines have been tried without success, and should be used together with diet and exercise.
Rybelsus tablets work to lower blood sugar (glucose) levels by increasing how much insulin is released and decreasing glucagon secretion. This medicine also may slow gastric emptying after eating. Rybelsus is from the class of medicines called GLP-1 receptor agonists.
Rybelsus is not for treating type 1 diabetes.
Rybelsus was first approved by the FDA on September 20, 2019.
Warnings
You should not use Rybelsus if you have multiple endocrine neoplasia type 2 (tumors in your glands), a personal or family history of medullary thyroid cancer, insulin-dependent diabetes, or diabetic ketoacidosis.
Call your doctor at once if you have signs of a thyroid tumor, such as swelling or a lump in your neck, trouble swallowing, a hoarse voice, or shortness of breath.